Sanofi Archives

News and Trends 31 May 2015

Who are the European Cancer Champions?

Cancer makes no difference… Children, elderly, healthy, disabled, black, white, etc… the disease randomly selects its targets. One of the biggest challenges of the Biotech industry today, is to lead groundbreaking innovations capable of treating cancer, which also encompass each individual’s biological specificity. So who are the leading champions? Recently, Thomson Reuters listed the 5 […]

May 31, 2015 - 2 minutesmins - By Alexandre Lowrey

News and Trends 22 May 2015

Genzyme joins the never-ending list of Ablynx’ partners

Genzyme is joining Ablynx’ partner list, which already includes AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co, Merck Serono and Novartis. The Sanofi subsidiary now wants to try out the Nanobody technology of Ablynx against a target at the origin of multiple sclerosis. Genzyme wants to investigate nanobodies against a target that specifically aligns with Genzyme’s early-stage multiple […]

May 22, 2015 - 2 minutesmins - By Joachim Eeckhout

ADN Que sont les Biotechnologies 1213x418

News and Trends 20 Apr 2015

So, what is actually Biotech?

Biotechnology is a broad domain, which includes numerous areas such as healing, feeding and fueling the world. Historically-speaking, the biotech sector started in the 80s with the discovery of gene cloning. The first “Biotech” ever born was Genentech (contraction of Gene and Technology), founded in South San Francisco, which successfully produced human insulin in bacteria. The Organisation […]

April 20, 2015 - 4 minutesmins - By Nicolas Sainte-Foie

metamorphosis biopharmceutical innovation bio europe spring 2015

News and Trends 26 Mar 2015

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Innovation can occur in many different ways, and biopharmaceutical innovation is no exception. The pipelines of big Pharmas have fewer candidates, R&D costs are skyrocketing, internal research programs tend to shrink and open innovation is raising. This metamorphosis is happening right now and the plenary session of Bio-Europe Spring 2015 focused on this subject. A great opportunity […]

March 26, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 12 Mar 2015

Sanofi and its Succesful Pivot from Chemistry to Biotechnology [BIO-Spring 2015]

Sanofi is France’s largest pharma company and the 3rd biggest in the World. The VIP guest of BIO-Europe Spring was Serge Weinberg, Chairman and temporary CEO of Sanofi. You might have been expecting a boring corporate conference with a strong Frenchy-accent English but actually, the talk was extremely clear and interesting. Weinberg went through Sanofi’s innovation strategy as […]

March 12, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 27 Feb 2015

Sanofi: Get Ready for the Launch of the First Inhaled Insulin in the U.S.

Sanofi, the global healthcare leader has core strengths in the field of healthcare due to its seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. This article will focus on Sanofi Diabetes. In August 2014, our previous article “Sanofi buys Mannkind’s inhaled insulin for €824.5m” […]

February 27, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 23 Feb 2015

Adimab, the secret weapon of the Big Pharma companies

After establishing discovery collaborations with over 30 companies during the past five years (Roche, Pfizer, Genentech, Novartis, Merck, Lilly, Celgene, Novo Nordisk and GSK), it is today with Sanofi that the biotech company Adimab enters into partnership for the development of bispecific antibodies. Adimab integrated antibody discovery and optimization platform, offers unprecedent speed to purify […]

February 23, 2015 - 2 minutesmins - By Cédric Brock

News and Trends 19 Feb 2015

Lead Pharma partners with Sanofi to beat Autoimmune Diseases

Lead Pharma is a pharmaceutical company developing innovative medicines for the treatment of autoimmune diseases and cancer. It has entered into a research collaboration with big-shot Sanofi to develop small molecule therapies directed against the nuclear hormone receptor ROR gamma t (RORyt) to treat a broad range of autoimmune disorders. A big news for this Netherland-based Biotech […]

February 19, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 29 Oct 2014

Sanofi Fires its CEO Chris Viehbacher

Breaking news for French Pharma company Sanofi. The Board decided to fire Christopher Viehbacher, who was leading the company since December 2008. Chris Viehbacher, German-Canadian, was the first non-French CEO of Sanofi, second largest French company. He had a tough management and tried to transform Sanofi (maybe too much). He managed Sanofi’s transition to Biotech/Biologicals with […]

October 29, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 19 Aug 2014

Sanofi buy Mannkind’s inhaled insulin for $925m

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter […]

August 19, 2014 - 3 minutesmins - By Joachim Eeckhout

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Sanofi

Who are the European Cancer Champions?

Genzyme joins the never-ending list of Ablynx’ partners

So, what is actually Biotech?

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Sanofi and its Succesful Pivot from Chemistry to Biotechnology [BIO-Spring 2015]

Sanofi: Get Ready for the Launch of the First Inhaled Insulin in the U.S.

Adimab, the secret weapon of the Big Pharma companies

Lead Pharma partners with Sanofi to beat Autoimmune Diseases

Sanofi Fires its CEO Chris Viehbacher

Sanofi buy Mannkind’s inhaled insulin for $925m

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!